Embedded Files
1. Symbol report for HGNC:990 . (2018). Retrieved December 4, 2018, from https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:990
2. BCL2 BCL2, apoptosis regulator [Homo sapiens (human)] - Gene - NCBI. (2018, December 8). Retrieved December 4, 2018, from https://www.ncbi.nlm.nih.gov/gene/596
3. Homo sapiens BCL2, apoptosis regulator (BCL2), RefSeqGene on chromosom - Nucleotide - NCBI. (2018, December 8). Retrieved December 10, 2018, from https://www.ncbi.nlm.nih.gov/nuccore/NG_009361.1
4. Homo sapiens BCL2, apoptosis regulator (BCL2), transcript variant alph - Nucleotide - NCBI. (2018, December 8). Retrieved December 10, 2018, from https://www.ncbi.nlm.nih.gov/nuccore/NM_000633.2
5. Apoptosis regulator Bcl-2 isoform alpha [Homo sapiens] - Protein - NCBI. (2018, December 8). Retrieved December 10, 2018, from https://www.ncbi.nlm.nih.gov/protein/NP_000624.2
6. Homo sapiens BCL2, apoptosis regulator (BCL2), transcript variant beta - Nucleotide - NCBI. (2018, December 8). Retrieved December 10, 2018, from https://www.ncbi.nlm.nih.gov/nuccore/NM_000657.2
7. Apoptosis regulator Bcl-2 isoform beta [Homo sapiens] - Protein - NCBI. (2018, December 8). Retrieved December 10, 2018, from https://www.ncbi.nlm.nih.gov/protein/NP_000648.2
8. (2018). Retrieved December 10, 2018, from http://useast.ensembl.org/Homo_sapiens/Transcript/Domainsa?db=core;fdb
9. (2018). Retrieved December 10, 2018, from http://useast.ensembl.org/Homo_sapiens/Transcript/Domainsb?db=core;fdb
10. 6GL8: Crystal structure of Bcl-2 in complex with the novel orally active inhibitor S55746. (2018). Retrieved December 10, 2018, from https://www.ncbi.nlm.nih.gov/Structure/pdb/6GL8
11. EMBL-EBI, I. (2018). InterPro. Retrieved December 10, 2018, from http://www.ebi.ac.uk/interpro/entry/IPR013278
12. Germain, M., & Shore, G. C. (2003). Cellular Distribution of Bcl-2 Family Proteins. Science Signaling, 2003(173). doi:10.1126/stke.2003.173.pe10
13. Bcl-2 Family. (2018). Retrieved December 10, 2018, from https://www.apexbt.com/research-area/apoptosis/bcl-2-family.html
14. European Bioinformatics InstituteProtein Information ResourceSIB Swiss Institute of Bioinformatics. (2018, November 07). Apoptosis regulator Bcl-2. Retrieved December 10, 2018, from https://www.uniprot.org/uniprot/P10415
15. European Bioinformatics InstituteProtein Information ResourceSIB Swiss Institute of Bioinformatics. (2018, November 07). Apoptosis regulator Bcl-2. Retrieved December 10, 2018, from https://www.uniprot.org/uniprot/P10415-2#sequences
16. RCSB Protein Data Bank. (2018). Apoptosis regulator Bcl-2 - P10415 (BCL2_HUMAN). Retrieved December 10, 2018, from http://www.rcsb.org/pdb/protein/P10415
17. Lomonosova, E., & Chinnadurai, G. (2008). BH3-only proteins in apoptosis and beyond: an overview. Oncogene, 27 Suppl 1(Suppl 1), S2-19.
18. BH1-4 Protein Domains. (n.d.). Retrieved December 10, 2018, from https://www.cellsignal.com/contents/resources-protein-domains-interactions/bh1-4-protein-domains/domains-bh14
19. NCBI CDD Conserved Protein Domain bcl-2. (2018). Retrieved December 10, 2018, from https://www.ncbi.nlm.nih.gov/Structure/cdd/cddsrv.cgi?ascbin=8&maxaln=10&seltype=2&uid=TIGR00865
20. Hardwick, J. M., & Soane, L. (2013). Multiple functions of BCL-2 family proteins. Cold Spring Harbor perspectives in biology, 5(2), 10.1101/cshperspect.a008722 a008722. doi:10.1101/cshperspect.a008722
21. Kang, M. H., & Reynolds, C. P. (2009). Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clinical cancer research : an official journal of the American Association for Cancer Research, 15(4), 1126-32.
22. Willis, S. (2003). The Bcl-2-regulated apoptotic pathway. Journal of Cell Science, 116(20), 4053-4056. doi:10.1242/jcs.00754
23. Dremina ES, Sharov VS, Kumar K, Zaidi A, Michaelis EK, Schoneich C 2004. Anti-apoptotic protein Bcl-2 interacts with and destabilizes the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase (SERCA). Biochem J 383: 361–370
24. Vanden Abeele F, Skryma R, Shuba Y, Van Coppenolle F, Slomianny C, Roudbaraki M, Mauroy B, Wuytack F, Prevarskaya N 2002. Bcl-2-dependent modulation of Ca2+ homeostasis and store-operated channels in prostate cancer cells. Cancer Cell 1: 169–179
25. Oakes SA, Scorrano L, Opferman JT, Bassik MC, Nishino M, Pozzan T, Korsmeyer SJ 2005. Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum. Proc Natl Acad Sci 102: 105–110
26. White C, Li C, Yang J, Petrenko NB, Madesh M, Thompson CB, Foskett JK 2005. The endoplasmic reticulum gateway to apoptosis by Bcl-xL modulation of the InsP3R. Nat Cell Biol 7: 1021–1028
27. Rong YP, Barr P, Yee VC, Distelhorst CW 2009. Targeting Bcl-2 based on the interaction of its BH4 domain with the inositol 1,4,5-trisphosphate receptor. Biochim Biophys Acta 1793: 971–978
28. Rockefeller University Press. (2009, September 27). Prolonged Stress Sparks Endoplasmic Reticulum To Release Calcium Stores And Induce Cell Death In Aging-related Diseases. ScienceDaily. Retrieved December 8, 2018 from www.sciencedaily.com/releases/2009/09/090914110518.htm
29. Kuida K (2000). "Caspase-9". The International Journal of Biochemistry & Cell Biology. 32 (2): 121–4. doi:10.1016/s1357-2725(99)00024-2. PMID 10687948.
30. Bcl-2 family. (2018, November 30). Retrieved December 10, 2018, from https://en.wikipedia.org/wiki/Bcl-2_family
31. Stephen F. Altschul, Thomas L. Madden, Alejandro A. Schäffer, Jinghui Zhang, Zheng Zhang, Webb Miller,and David J. Lipman (1997), "Gapped BLAST and PSI-BLAST: a new generation of protein database search programs", Nucleic Acids Res. 25:3389-3402.
32. AceView: Gene:BCL2, a comprehensive annotation of human, mouse and worm genes with mRNAs or ESTsAceView. (2018). Retrieved December 10, 2018, from https://www.ncbi.nlm.nih.gov/IEB/Research/Acembly/av.cgi?db=human&term=bcl2&submit=Go
33. Bagga, Paramjeet. S. Bioinformatics, Genomics, Proteomics. 8 December. Ramapo College of New Jersey. https://pages.ramapo.edu/~pbagga/cmb/bioinformatics_genomics_proteomics_ho.pdf
34. Lapidus, Alla L. “Bioinformatics and Its Applications .” Bioinformatics Institute St Petersburg, https://bioinformaticsinstitute.ru/sites/default/files/lapidus_1_0.pdf.
35. Ouzounis, Christos A. “Rise and Demise of Bioinformatics? Promise and Progress.” NCBI, PLOS Computational Biology , 26 Apr. 2012, www.ncbi.nlm.nih.gov/pmc/articles/PMC3343106/
36. Thampi, Sabu M. “Bioinformatics .” Arxiv, LBS College of Engineering ,www.arxiv.org/pdf/0911.4230.pdf
37. Kollek, Matthias, et al. “Bcl‐2 Proteins in Development, Health, and Disease of the Hematopoietic System.” FEBS Letters, Wiley-Blackwell, 21 Mar. 2016, http://febs.onlinelibrary.wiley.com/doi/full/10.1111/febs.13683
38. Cohen, Jonathan M., et al. “Successful Treatment of Lymphoproliferative Disease Complicating Primary Immunodeficiency/Immunodysregulatory Disorders with Reduced-Intensity Allogeneic Stem-Cell Transplantation.” Blood Journal, American Society of Hematology, 15 Sept. 2007, www.bloodjournal.org/content/110/6/2209?sso-checked=true.
39. “Thrombocytopenia (Low Platelet Count).” Mayo Clinic, Mayo Foundation for Medical Education and Research, 3 Apr. 2018, www.mayoclinic.org/diseases-conditions/thrombocytopenia/symptoms-causes/syc-20378293.
40. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. 2005. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci 102: 15545–15550.
41. Liao G (12 August 2011). "ABT-199 BH-3 Mimetic Enters Phase Ia Trial For Chronic Lymphocytic Leukemia". Asian Scientist. Archived from the original on 18 July 2012.
42. Roberts AW, Davids MS, Pagel JM, Kahl BS, Puvvada SD, Gerecitano JF, Kipps TJ, Anderson MA, Brown JR, Gressick L, Wong S, Dunbar M, Zhu M, Desai MB, Cerri E, Heitner Enschede S, Humerickhouse RA, Wierda WG, Seymour JF (January 2016). "Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia". The New England Journal of Medicine. 374 (4): 311–22. doi:10.1056/NEJMoa1513257. PMID 26639348.
43. Bankhead C (11 April 2016). "FDA Approves AbbVie's BCL-2 Targeting Drug for CLL". Medpage Today.
44. “MYC Gene.” ESPL1 Gene - GeneCards | ESPL1 Protein | ESPL1 Antibody, www.genecards.org/cgi-bin/carddisp.pl?gene=MYC.
45. “Burkitt Lymphoma.” Genetic and Rare Diseases Information Center, U.S. Department of Health and Human Services, http://rarediseases.info.nih.gov/diseases/5973/burkitt-lymphoma.
46. Younes, Anas, et, al. “The Landscape of New Drugs in Lymphoma.” NCBI, NAT REV CLIN ONCOLOGY, 25 Sept. 2017, www.ncbi.nlm.nih.gov/pmc/articles/PMC5611863/.
Google Sites
Report abuse